Twin Health announced that it raised $140 million in a Series C financing round as it scales its service in the U.S. and globally.
Mountain View, California-based Twin Health develops the Whole Body Digital Twin platform designed to help reverse and prevent chronic metabolic diseases while improving energy and health.
According to a news release, the artificial intelligence-powered Whole Body Digital Twin platform represents each individual’s unique metabolism, built from thousands of data points collected daily through non-invasive, wearable sensors and self-reported preferences. The predictive model provides individualized nutrition, sleep, activity and breathing guidance to patients and healthcare providers in an effort to reverse and prevent multiple chronic metabolic diseases, including type 2 diabetes.
The platform includes continuous glucose monitors (CGMs), fitness watches, comprehensive blood tests and the development of each member’s individualized Whole Body Digital Twin, along with consultations with healthcare providers and company coaches.
Early data from a randomized controlled trial of Twin Health’s technology, presented and published in the American Diabetes Association’s Diabetes journal, demonstrated an average HbA1c reduction of 3.1 (average baseline 8.7) with over 80% achieving type 2 diabetes reversal (HbA1c less than 6.5) and 92% eliminating all diabetes medications including insulin. Additionally, patients had an average weight reduction of 20 lbs.
Funding for the company’s efforts to expand its platform came from the likes of ICONIQ Growth, Sequoia Capital India, Perceptive Advisors, Corner Ventures, LTS Investments, Helena and Sofina.
“We are each gifted a body. If given a chance, it can heal itself,” Twin Health founder & CEO Jahangir Mohammed said in the release. “Our Whole Body Digital Twin lives alongside you – giving you a view into your beautifully complex biology, continuously learning about your metabolism and telling you what you can do to improve your health in the moment.”
